Literature DB >> 7618438

Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32.

K Wakabayashi1, L A Hansen, E Masliah.   

Abstract

To characterize neurons containing cortical Lewy bodies (LBs), vibratome sections of the superior temporal cortex from eight patients with the LB variant of Alzheimer's disease (LBV) were double-immunolabeled with anti-ubiquitin (a marker of LBs) and anti-nonphosphorylated neurofilament (SMI32; a marker of pyramidal cells) or parvalbumin (PV; a marker of interneurons) and were viewed with a laser-scanning confocal microscope. Almost all (96.1%) the LB-containing neurons were positive for SMI32, but not for PV. Furthermore, the average numbers of SMI32-immunoreactive neurons in layers 3 and 5 were 63% and 77% of those in controls, respectively. PV-immunoreactive neurons showed a greater than 40% decrease. These findings indicate that cortical LB-containing neurons are pyramidal cells and suggest that in LBV, there may be some differences in the degenerative processes effecting pyramidal cells and interneurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7618438     DOI: 10.1007/BF00307643

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  42 in total

1.  Ca2+/calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies.

Authors:  T Iwatsubo; I Nakano; K Fukunaga; E Miyamoto
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  Pathology and biology of the Lewy body.

Authors:  M S Pollanen; D W Dickson; C Bergeron
Journal:  J Neuropathol Exp Neurol       Date:  1993-05       Impact factor: 3.685

3.  Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.

Authors:  G Lennox; J Lowe; M Landon; E J Byrne; R J Mayer; R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

4.  Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex.

Authors:  R O Kuljis; P Martín-Vasallo; N S Peress
Journal:  Neurosci Lett       Date:  1989-11-20       Impact factor: 3.046

5.  Immunohistochemical localization of Ca2+/calmodulin-dependent protein kinase II in rat brain and various tissues.

Authors:  K Fukunaga; S Goto; E Miyamoto
Journal:  J Neurochem       Date:  1988-10       Impact factor: 5.372

6.  Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease.

Authors:  L A Hansen; R DeTeresa; P Davies; R D Terry
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

7.  Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

Authors:  C L Joachim; J H Morris; D J Selkoe
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

8.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

9.  Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.

Authors:  R H Perry; D Irving; G Blessed; A Fairbairn; E K Perry
Journal:  J Neurol Sci       Date:  1990-02       Impact factor: 3.181

10.  Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex.

Authors:  J DeFelipe; S H Hendry; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more
  12 in total

Review 1.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

2.  Histone H3 acetylation in the postmortem Parkinson's disease primary motor cortex.

Authors:  Kibrom G Gebremedhin; David J Rademacher
Journal:  Neurosci Lett       Date:  2016-05-27       Impact factor: 3.046

Review 3.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

4.  Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology.

Authors:  David H Adamowicz; Subhojit Roy; David P Salmon; Douglas R Galasko; Lawrence A Hansen; Eliezer Masliah; Fred H Gage
Journal:  J Neurosci       Date:  2016-12-30       Impact factor: 6.167

5.  Lewy body cortical involvement may not always predict dementia in Parkinson's disease.

Authors:  C Colosimo; A J Hughes; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

6.  Alpha-synuclein pathology in the olfactory pathways of dementia patients.

Authors:  Paul S Hubbard; Margaret M Esiri; Margaret Reading; Rupert McShane; Zsuzsanna Nagy
Journal:  J Anat       Date:  2007-06-06       Impact factor: 2.610

Review 7.  Parkinson's Disease Is Not Simply a Prion Disorder.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  J Neurosci       Date:  2017-10-11       Impact factor: 6.167

8.  Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.

Authors:  R Thangavel; S K Sahu; G W Van Hoesen; A Zaheer
Journal:  Neuroscience       Date:  2009-02-27       Impact factor: 3.590

9.  Expression of Kv3.1b potassium channel is widespread in macaque motor cortex pyramidal cells: A histological comparison between rat and macaque.

Authors:  David Soares; Isabelle Goldrick; Roger N Lemon; Alexander Kraskov; Linda Greensmith; Bernadett Kalmar
Journal:  J Comp Neurol       Date:  2017-03-14       Impact factor: 3.215

Review 10.  Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.

Authors:  Nelson de Oliveira Manzanza; Lucia Sedlackova; Raj N Kalaria
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.